ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $99,000 | -29.3% | 48,618 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $140,000 | +351.6% | 48,618 | +1114.8% | 0.00% | – |
| Q2 2019 | $31,000 | -97.7% | 4,002 | -93.7% | 0.00% | -100.0% |
| Q4 2017 | $1,373,000 | -9.3% | 64,007 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $1,514,000 | +253.7% | 64,007 | +194.3% | 0.01% | +250.0% |
| Q2 2017 | $428,000 | -40.2% | 21,751 | -36.2% | 0.00% | -33.3% |
| Q1 2017 | $716,000 | – | 34,116 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |